FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Esteban Ribera

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1

Procedures

Concepts & Ideas

Geographic Areas

Spain

Co-author Network

Publications

TOP 3
Daniel Podzamczer; Joaquín Portilla; Esteban Ribera; Ignacio Santos; Ferrán Segura; Pompeyo E. Viciana; Antonio Antela; Jorge Carmena; Manuel Castaño; Jordi Curto; Pere Domingo; Vicente Estrada; Elena Ferrer; Josefa Galindo; Hernando Knobel; Esteban Martínez; Eugenia Negredo; Antonio Ocampo; Maria-Jesús Pérez-Elías
Switching to raltegravir in virologically suppressed in HIV-1-infected patients: a retrospective, multicenter, descriptive study.
Maria Saumoy; Esteban Ribera; José Luis Sánchez-Quesada; Bonaventura Clotet; Adrian Curran; Jordi Curto; Josep Maria Gatell; Hernando Knobel; Josep Maria Llibre; Esteban Martínez; Margarita Masó; Jordi Ordoñez-Llanos; Daniel Podzamczer
LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: Spiral substudy.
Adrian Curran; Vicenç Falcó; Albert Pahissa; Esteban Ribera
Management of tuberculosis in HIV-infected patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Esteban Ribera (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Daniel Podzamczer; Joaquín Portilla; Esteban Ribera; Ignacio Santos; Ferrán Segura; Pompeyo E. Viciana; Antonio Antela; Jorge Carmena; Manuel Castaño; Jordi Curto; Pere Domingo; Vicente Estrada; Elena Ferrer; Josefa Galindo; Hernando Knobel; Esteban Martínez; Eugenia Negredo; Antonio Ocampo; Maria-Jesús Pérez-Elías
Switching to raltegravir in virologically suppressed in HIV-1-infected patients: a retrospective, multicenter, descriptive study.
Current HIV research 2012;10(8):673-8.
2012: Maria Saumoy; Esteban Ribera; José Luis Sánchez-Quesada; Bonaventura Clotet; Adrian Curran; Jordi Curto; Josep Maria Gatell; Hernando Knobel; Josep Maria Llibre; Esteban Martínez; Margarita Masó; Jordi Ordoñez-Llanos; Daniel Podzamczer
LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: Spiral substudy.
Atherosclerosis 2012;225(1):200-7.
2012: Adrian Curran; Vicenç Falcó; Albert Pahissa; Esteban Ribera
Management of tuberculosis in HIV-infected patients.
AIDS reviews 2012;14(4):231-46.
2012: Daniel Podzamczer; T Puig; Esteban Ribera; I Santos; J M Tiraboschi; Concepción Villalonga; M A Cárdenes; S Echevarría; J A García-Henarejos; J L Gómez-Sirvent; J C Lopez Bernaldo de Quirós; Pilar Barrufet; E Casas; A Castro; J Curto; Lluís Force; M Leal; J Lopez-Aldeguer; Josep Mallolas; Santiago Moreno; J Sanz
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 years.
Current HIV research 2012;10(6):513-20.
2012: Adrian Curran; Luis del Rio; Pere Domingo; Jose Maria Gatell; María Larrousse; Montserrat Lonca; Esteban Martinez; Daniel Podzamczer; Joaquin Burgos; Manuel Crespo; Maria Saumoy; Esteban Ribera
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy.
AIDS (London, England) 2012;26(4):475-81.
2012: Adria Curran; Vicenç Falco; Jose Maria Gatell; Arkaitz Imaz; Montserrat Lonca; Esteban Martinez; Maria Martinez; Daniel Podzamczer; Patricia Barragan; Manuel Crespo; Sergio Vidal-Sicart; Esteban Ribera
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trial.
Antiviral therapy 2012;17(4):711-8.
2011: Adrian Curran; Esteban Ribera
HIV and TB coinfection: using adjusted doses of lopinavir/ritonavir with rifampin.
Expert review of anti-infective therapy 2011;9(12):1115-8.
2011: Elena Ferrer; Josep M Gatell; Esteban Martínez; Eugenia Negredo; Jordi Ordóñez; Esteban Ribera; Joaquim Rosales; Maria Saumoy; Luis del Rio; Jordi Curto; Pere Domingo; Daniel Podzamczer
Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adults.
AIDS research and human retroviruses 2011;27(10):1061-5.
2011: José R Santos; Sebastián Videla; Isabel Bravo; Pere Domingo; Elena Ferrer; Arkaitz Imaz; Josep M Llibre; Daniel Podzamczer; Esteban Ribera; Bonaventura Clotet
Short communication: high effectiveness of etravirine in routine clinical practice in treatment-experienced HIV type 1-infected patients.
AIDS research and human retroviruses 2011;27(7):713-7.
2011: Esteban Ribera; Montserrat Tuset; Maite Martín; Elena del Cacho
[Characteristics of antiretroviral drugs].
Enfermedades infecciosas y microbiología clínica 2011;29(5):362-91.
2011: Adrian Curran; Esteban Ribera
From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.
Expert opinion on drug safety 2011;10(3):389-406.
2011: Arkaitz Imaz; Josep M Llibre; Marta Mora; Gracia Mateo; Angela Camacho; José R Blanco; Adria Curran; José R Santos; Estrella Caballero; Isabel Bravo; Francisco Gayá; Pere Domingo; Antonio Rivero; Vicenç Falcó; Bonaventura Clotet; Esteban Ribera
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.
The Journal of antimicrobial chemotherapy 2011;66(2):358-62.
2011: Eva Van den Eynde; María Cubero; Adria Curran; Juan I Esteban; Vicenç Falco; Damir Garcia-Cehic; María Homs; Albert Pahissa; Josep Quer; Esteban Ribera; Manuel Crespo
Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system.
Antiviral therapy 2011;16(6):887-93.
2011: Maria Saumoy; Patricia Barragán; Rosa Bonet; Adrian Curran; Josep Maria Gatell; Hernando Knobel; Montserrat Loncá; Esteban Martínez; Eugenia Negredo; Jordi Ordoñez-Llanos; Daniel Podzamczer; Esteban Ribera
Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir.
Antiviral therapy 2011;16(4):459-68.
2011: José A Pérez-Molina; Ignacio Suárez-Lozano; A Del Arco; R Teira; P Bachiller; Vicente Navarro Lopez; E Martínez-Alfaro; Pere Domingo; A Mariño; Esteban Ribera; Antonio Antela; J de Otero; V Navarro; Juan González-García
Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant status.
HIV clinical trials 2011;12(1):1-8.
2010: Adrian Curran; Mar Gutirerrez; Elisabet Deig; Gracia Mateo; Rosa Maria Lopez; Arkaitz Imaz; Manuel Crespo; Imma Ocaña; Pere Domingo; Esteban Ribera
Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients.
The Journal of antimicrobial chemotherapy 2010;65(10):2195-203.
2010: Vicente Navarro Lopez; O Serrano; J Carmena; V Asensi; S Echevarría; J Flores; Esteban Ribera; M Zarraga; A Ocampo; B de la Fuente; M A Sepúlveda; A I Mariño; C Minguez; R Vicent; J A Cartón; B Moyano; H Esteban; B Mahillo; L Serrano; J González-García
Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.
HIV medicine 2010;11(9):545-53.
2010: José M Miró; Christian Manzardo; Judith Pich; Pere Domingo; Elena Ferrer; José R Arribas; Esteban Ribera; Julio Arrizabalaga; Montserrat Loncá; Anna Cruceta; Elisa de Lazzari; montserrat fuster; Daniel Podzamczer; Montserrat Plana; José M Gatell
Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.
AIDS research and human retroviruses 2010;26(7):747-57.
2010: Ramón Teira; Ignacio Suárez-Lozano; Fernando Lozano; Pompeyo E. Viciana; Pere Domingo; Pepa Galindo; Paloma Geijo; Alberto Terrón; Juan González; Jaime Cosín; Esteban Ribera; Bernardino Roca; María L García-Alcalde; Trinitario Sánchez; Agustín Muñoz-Sánchez; Antonio Vergara; José López Aldeguer; Enric Pedrol; Francesc Vidal; Myriam Garrido; Juan M Santamaría
Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort.
Enfermedades infecciosas y microbiología clínica 2010;28(5):266-72.
2009: Beatriz Mothe; Iñaki Perez; Pere Domingo; Daniel Podzamczer; Esteban Ribera; Adrian Curran; Consuelo Viladés; Francesc Vidal; David Dalmau; Enric Pedrol; Eugenia Negredo; José Moltó; Roger Paredes; Núria Perez-Alvarez; Jose Maria Gatell; Bonaventura Clotet
HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain.
Current HIV research 2009;7(6):597-600.
2009: Arkaitz Imaz; Sara Villar del Saz; M Angels Ribas; Adria Curran; Estrella Caballero; Vicenç Falcó; Manuel Crespo; Imma Ocaña; Marjorie Diaz; Enrique Ruiz de Gopegui; Melcior Riera; Esteban Ribera
Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):382-6.
2009: Pere Domingo; Ignacio Suarez-Lozano; Ferran Torres; Virginia Pomar; Esteban Ribera; Ma Jose Galindo; Jaime Cosin; Ma Luisa Garcia-Alcalde; Francesc Vidal; Jose Lopez-Aldeguer; Bernardino Roca; Juan Gonzalez; Fernando Lozano; Myriam Garrido
Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2009;51(5):582-7.
2009: Esteban Martínez; José A Arranz; Daniel Podzamczer; Montserrat Loncá; José Sanz; Patricia Barragán; Esteban Ribera; Hernando Knobel; Victor Roca; Félix Gutiérrez; José L Blanco; Josep Mallolas; Josep M Llibre; Bonaventura Clotet; David Dalmau; Ferran Segura; José R Arribas; Jaime Cosín; Pilar Barrufet; Esperanza Casas; Elena Ferrer; Adrià Curran; Alicia González; Judit Pich; Ana Cruceta; Joan A Arnaiz; José M Miró; José M Gatell
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.
Journal of acquired immune deficiency syndromes (1999) 2009;51(3):290-7.
2009: Daniel Podzamczer; Elena Ferrer; Esteban Martínez; Luis Del Rio; Joaquín Rosales; Jordi Curto; Esteban Ribera; Pilar Barrufet; Josep M Llibre; Miquel Aranda
How much fat loss is needed for lipoatrophy to become clinically evident?
AIDS research and human retroviruses 2009;25(6):563-7.
2009: Eva Van den Eynde; Manuel Crespo; Juan Ignacio Esteban; Rosend Jardi; Esteban Ribera; Judit Carbonell; Francisco Rodríguez-Frias; Vicenç Falco; Adria Curran; Arkaitz Imaz; Sara Villar del Saz; Imma Ocaña; Rafael Esteban; Albert Pahissa
Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(8):1152-9.
2008: Isabel Campos-Varela; Oscar Len; Lluis Castells; Natalia Tallada; Esteban Ribera; Cristina Dopazo; Víctor Vargas; Joan Gavaldà; Ramón Charco
Visceral leishmaniasis among liver transplant recipients: an overview.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(12):1816-9.
2008: Adria Curran; Vicenç Falcó; Manuel Crespo; X Martinez; Esteban Ribera; S Villar del Saz; A Imaz; E Coma; Adelaida Ferrer; Albert Pahissa
Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome.
HIV medicine 2008;9(8):609-15.
2008: Míriam J Alvarez-Martínez; Asunción Moreno; José M Miró; Maria Eugenia Valls; Paula V Rivas; Elisa de Lazzari; Omar Sued; Natividad Benito; Pere Domingo; Esteban Ribera; Miguel Santín; Guillermo Sirera; Ferràn Segura; Francesc Vidal; Francisco Rodríguez; Melchor Riera; Maria Elisa Cordero; José Ramón Arribas; Maria Teresa Jiménez de Anta; José M Gatell; Paul E Wilson; Steven R Meshnick
Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.
Diagnostic microbiology and infectious disease 2008;62(1):34-43.
2008: Pere Domingo; Ignacio Suárez-Lozano; Ferran Torres; Ramón Teira; José Lopez-Aldeguer; Francesc Vidal; Agustín Muñoz; Pompeyo E. Viciana; Fernando Lozano; Antonio Vergara; Bernadino Roca; Ma Luisa García Alcalde; Jaime Cosín; Alberto Terrón; Ma José Galindo; Paloma Geijo; Esteban Ribera; Juan Gonzalez; Trinitario Sanchez; Juan Ramón Lacalle; Myriam Garrido
First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort.
The Journal of antimicrobial chemotherapy 2008;61(6):1348-58.
2008: Roser Fisa; Cristina Riera; Paulo López-Chejade; Israel Molina; Montserrat Gállego; Vicenç Falcó; Esteban Ribera; Montserrat Portús
Leishmania infantum DNA detection in urine from patients with visceral leishmaniasis and after treatment control.
The American journal of tropical medicine and hygiene 2008;78(5):741-4.
2008: Pompeyo E. Viciana; Rafael Rubio; Esteban Ribera; Hernando Knobel; José A Iribarren; José R Arribas; José A Pérez-Molina
[Longitudinal study on adherence, treatment satisfaction, and effectiveness of once-daily versus twice-daily antiretroviral therapy in a Spanish cohort of HIV-infected patients (CUVA study)].
Enfermedades infecciosas y microbiología clínica 2008;26(3):127-34.
2008: Esteban Ribera; Adria Curran
Double-boosted protease inhibitor antiretroviral regimens: what role?
Drugs 2008;68(16):2257-67.
2008: Manuel Crespo; Isabel Caragol; Vicenç Falcó; Esteban Ribera; Susana Urban; Albert Pahissa
Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAART.
Enfermedades infecciosas y microbiología clínica 2008;26(1):27-31.
2007: María Peñaranda; Vicenç Falco; Antoni Payeras; Queralt Jordano; Adria Curran; Antonio Pareja-Bezares; Gloria Samperiz; David Dalmau; Esteban Ribera; Melcior Riera
Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(7):e82-7.
2007: Israel Molina; Vicenç Falcó; Manuel Crespo; Cristina Riera; Esteban Ribera; Adria Curran; J Carrio; Marjorie Diaz; S Villar del Saz; Roser Fisa; P López-Chejade; Imma Ocaña; Albert Pahissa
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
The Journal of antimicrobial chemotherapy 2007;60(4):837-42.
2007: Enric Pedrol; Teodoro Martín; Miguel Angel del Pozo; Juan Flores; José Sanz; José A Cartón; Juan-José Jusdado; Piedad Arazo; Esteban Ribera; Elisabet Deig
[Efficacy and safety of a reduced-dose of stavudine in HIV-infected patients under immunological and virological stable conditions].
Medicina clínica 2007;129(10):361-5.
2007: Manuel Crespo; Silvia Sauleda; Juan Ignacio Esteban; A Juarez; Esteban Ribera; A L Andreu; Vicenç Falco; Josep Quer; Imma Ocaña; Isabel Ruiz; Maria Buti; Albert Pahissa; Rafael Esteban; Jaime Guardia
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.
Journal of viral hepatitis 2007;14(4):228-38.
2007: Andrew Hill; Kiat Ruxrungtham; Mattana Hanvanich; Christine Katlama; Eva Wolf; Vincent Soriano; Ana Milinkovic; José M Gatell; Esteban Ribera
Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.
Expert opinion on pharmacotherapy 2007;8(5):679-88.
2007: Esteban Ribera; Carlos Azuaje; Rosa M Lopez; Pere Domingo; Adria Curran; Maria Feijoo; Leonor Pou; Paquita Sánchez; Maria Antonia Sambeat; Joan Colomer; Josep Lluis Lopez-Colomes; Manuel Crespo; Vicenç Falcó; Imma Ocaña; Albert Pahissa
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
The Journal of antimicrobial chemotherapy 2007;59(4):690-7.
2007: Manuel Crespo; Juan Ignacio Esteban; Esteban Ribera; Vicenç Falco; Silvia Sauleda; Maria Buti; Rafael Esteban; Jaime Guardia; Imma Ocaña; Albert Pahissa
Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients.
AIDS (London, England) 2007;21(4):477-81.
2007: Lluis Castells; Alfredo Escartín; Itxarone Bilbao; Oscar Len; Helena Allende; Víctor Vargas; Esteban Ribera; José-Luis Lázaro; Javier Bueno; Joaquin Balsells; Rafael Esteban; Albert Pahissa; Carlos Margarit
Liver transplantation in HIV-HCV coinfected patients: a case-control study.
Transplantation 2007;83(3):354-8.
2007: Esteban Ribera; Santiago Moreno; Pompeyo E. Viciana; Santiago Echevarría; Juan Flores; Adela Francés; Juan Luis Gómez Sirvent; Juan González; José Hernández Quero; Fernando Lozano; Josep Mallolas; Agustín Muñoz; Antonio Ocampo; Joaquín Portilla; Federico Pulido; Antonio Rivero; Jesús Santos; Vicente Soriano; Antonio Antela; Piedad Arazo; José R Arribas; Manel Cervantes; Pere Domingo
[Spanish recommendations for proper use of enfuvirtide].
Enfermedades infecciosas y microbiología clínica 2007;25(2):131-42.
2007: Daniel Podzamczer; Elena Ferrer; Pochita Sanchez; José M Gatell; Manel Crespo; Cesar Fisac; Montserrat Lonca; Jose Sanz; Jordi Niubo; Sergio Veloso; Josep M Llibre; Pilar Barrufet; María A Ribas; Esperanza Merino; Esteban Ribera; Javier Martínez-Lacasa; Carlos Alonso; Miquel Aranda; Federico Pulido; Juan Berenguer; Antonio Delegido; José Pedreira; Ana Lérida; Rafael Rubio; Luis del Río
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):139-47.
2007: Esteban Martínez; Juan A Arnaiz; Daniel Podzamczer; David Dalmau; Esteban Ribera; Pere Domingo; Hernando Knobel; María Leyes; Enric Pedrol; Lluís Force; Elisa De Lazzari; José M Gatell
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients.
AIDS (London, England) 2007;21(3):367-9.
2007: Manuel Crespo; Leonor Pou; Juan Ignacio Esteban; Vicenç Falcó; Esteban Ribera; Rosa Lopez; Silvia Sauleda; Adria Curran; Sara Villar del Saz; Maria Feijoo; Imma Ocaña; Albert Pahissa
Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients.
Antiviral therapy 2007;12(8):1217-23.
2006: Cecilia Cabrera; Silvia Marfil; Elisabet García; Javier Martinez-Picado; Anna Bonjoch; Margarita Bofill; Santiago Moreno; Esteban Ribera; Pere Domingo; Bonaventura Clotet; Lidia Ruiz
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.
AIDS (London, England) 2006;20(16):2075-80.
2006: Jose M Miro; Juan C Lopez; Daniel Podzamczer; Jose Peña; Juan C Alberdi; Esteban Martínez; Pere Domingo; Jaime Cosin; Xavier Claramonte; José R Arribas; Miguel Santín; Esteban Ribera
Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(1):79-89.
2006: Esteban Ribera; Carlos Azuaje; Rosa M Lopez; Marjorie Diaz; Maria Feijoo; Leonor Pou; Manuel Crespo; Adria Curran; Imma Ocaña; Albert Pahissa
Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen.
AIDS (London, England) 2006;20(8):1131-9.
2006: Carlos Azuaje; Núria Fernández Hidalgo; Benito Almirante; Nuria Martín-Casabona; Esteban Ribera; Marjorie Díaz; Guillem Prats; Albert Pahissa
[Tuberculous meningitis: a comparative study in relation to concurrent human immunodeficiency virus infection].
Enfermedades infecciosas y microbiología clínica 2006;24(4):245-50.
2006: Anna Bonjoch; Roger Paredes; Pere Domingo; Manel Cervantes; Enric Pedrol; Esteban Ribera; Lluís Force; Josep M Llibre; Josep Vilaró; David Dalmau; Josep Cucurull; Jaume Mascaró; Angels Masabeu; Núria Pérez-Alvarez; Jordi Puig; Denise Cinquegrana; Bonaventura Clotet
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.
AIDS research and human retroviruses 2006;22(4):321-9.
2006: Vicenç Falcó; Queralt Jordano; María-Jesús Cruz; Oscar Len; Esteban Ribera; Magda Campins; Manuel Crespo; Imma Ocaña; María-José Rodrigo; Albert Pahissa
Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.
Vaccine 2006;24(14):2567-74.
2006: Lluis Castells; Juan Ignacio Esteban; Itxarone Bilbao; Víctor Vargas; Helena Allende; Esteban Ribera; Maria Piron; Silvia Sauleda; Oscar Len; Albert Pahissa; Rafael Esteban; Jaime Guardia; Carlos Margarit
Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
Antiviral therapy 2006;11(8):1061-70.
2005: Cristina Riera; Roser Fisa; Esteban Ribera; Jaume Carrió; Vicenç Falcó; Montserrat Gállego; Lluis Moner; Israel Molina; Montserrat Portús
Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with leishmania and human immunodeficiency virus.
The American journal of tropical medicine and hygiene 2005;73(6):1012-5.
2005: Esteban Ribera; Carlos Azuaje; Rosa M Lopez; Pere Domingo; Alex Soriano; Leonor Pou; Paquita Sánchez; Josep Mallolas; Maria Antonia Sambea; Vicenç Falco; Imma Ocaña; Josep Lluis Lopez-Colomes; José M Gatell; Albert Pahissa
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):317-23.
2005: Federico Pulido; Esteban Ribera; Santiago Moreno; A Muñoz; Daniel Podzamczer; M A del Pozo; Antonio Rivero; F Rodríguez; I Sanjoaquín; Ramón Teira; Pompeyo E. Viciana; Concepción Villalonga; Antonio Antela; J Carmena; J Ena; E Gonzalez; José María Kindelán; Josep Mallolas; M Márquez; E Martínez
Once-daily antiretroviral therapy: Spanish Consensus Statement.
The Journal of antimicrobial chemotherapy 2005;56(5):808-18.
2005: Anna Ochoa de Echagüen; Mireia Arnedo; Mariona Xercavins; Esteban Martinez; Beatriz Rosón; Esteban Ribera; Pere Domingo; Alicia González; Melcior Riera; Josep M Llibre; José M Gatell; David Dalmau
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir.
AIDS (London, England) 2005;19(13):1385-91.
2005: Esteban Ribera; Luis Lopez-Cortes; Vicente Soriano; José L Casado; Josep Mallolas
Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?
Enfermedades infecciosas y microbiología clínica 2005;23 Suppl 2():41-67.
2005: Cesar Fisac; Emilio Fumero; Manel Crespo; Beatriz Roson; Elena Ferrer; Nuria Virgili; Esteban Ribera; José M Gatell; Daniel Podzamczer
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.
AIDS (London, England) 2005;19(9):917-25.
2005: Ramón Teira; Ignacio Suárez-Lozano; Pepa Muñoz; Pompeyo E. Viciana; Fernando Lozano; María José Galindo; Alberto Terrón; Antonio Vergara; Paloma Geijo; José R Arribas; Jaime Cosín; Pere Domingo; Esteban Ribera; Bernardino Roca; M Luisa García-Alcalde; Trinitario Sánchez; Agustín Muñoz-Sanz
[Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)].
Enfermedades infecciosas y microbiología clínica 2005;23(4):213-7.
2005: Esteban Ribera; Dolors Rodríguez Pardo; Manuel Rubio; Anna Soler; Enric Pedrol; José L Blanco; Alicia González; Manuel Crespo; Vicenç Falcó; Imma Ocaña; Elisabet Deig; José M Miró; Albert Pahissa
Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.
Antiviral therapy 2005;10(5):605-14.
2004: Cristina Riera; Roser Fisa; P Lopez; Esteban Ribera; Jaume Carrió; Vicenç Falcó; Israel Molina; Montserrat Gállego; Montserrat Portús
Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(12):899-904.
2004: José A Iribarren; Pablo Labarga; Rafael Rubio; Juan Berenguer; José M Miró; Antonio Antela; Juan González; Santiago Moreno; Julio Arrizabalaga; Lourdes Chamorro; Bonaventura Clotet; José M Gatell; José López Aldeguer; Esteban Martínez; Rosa Polo; Montserrat Tuset; Pompeyo E. Viciana; Juan Miguel Santamaría; José María Kindelán; Esteban Ribera; Ferran Segura
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].
Enfermedades infecciosas y microbiología clínica 2004;22(10):564-642.
2004: Esteban Ribera; Rosa M Lopez; Marjorie Diaz; Leonor Pou; Lidia Ruiz; Vicenç Falcó; Manuel Crespo; Carlos Azuaje; Isabel Ruiz; Imma Ocaña; Bonaventura Clotet; Albert Pahissa
Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.
Antimicrobial agents and chemotherapy 2004;48(11):4256-62.
2004: Hernando Knobel; José M Miró; Beatriz Mahillo; Pere Domingo; Antonio Rivero; Esteban Ribera; Juan Gonzalez; José Sanz; Alicia González; José L Blanco; Vicente Boix; Lluís Force; Josep M Llibre; David Dalmau; Juan A Arroyo; Julián De la Torre; Dolors Rodriguez; María Luisa Montes; Alberto Arranz; María Sarasa
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1276-81.
2004: Maria Saumoy; Francesc Vidal; Joaquim Peraire; Silvia Sauleda; Albert Martínez Vea; Consuelo Viladés; Esteban Ribera; Cristóbal Richart
Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?
AIDS (London, England) 2004;18(12):1741-2.
2004: Elena Ferrer; Elena Santamariña; Pere Domingo; Emilio Fumero; Esteban Ribera; Hernando Knobel; Juan Carlos Lopez; Ana Barrios; Daniel Podzamczer
Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or less.
AIDS (London, England) 2004;18(12):1727-9.
2004: Eugenia Negredo; José Moltó; Jose Munoz-Moreno; Enric Pedrol; Esteban Ribera; Pompeyo E. Viciana; M José Galindos; Celia Miralles; David Burger; Carmina Rodriguez Fumaz; Jordi Puig; Silvia Gel; Eva Rodríguez; Sebastián Videla; Lidia Ruiz; Bonaventura Clotet
Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach.
Antiviral therapy 2004;9(3):335-42.
2004: Queralt Jordano; Vicenç Falcó; Benito Almirante; Ana M Planes; Oscar del Valle; Esteban Ribera; Oscar Len; Carlos Pigrau; Albert Pahissa
Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(11):1623-8.
2004: Juan Berenguer; Fernando Laguna; José López Aldeguer; Santiago Moreno; José R Arribas; Julio Arrizabalaga; Josu Baraia; José L Casado; Jaime Cosín; Rosa Polo; Juan González-García; José A Iribarren; José María Kindelán; Juan C López-Bernaldo De Quirós; Rogelio López-Vélez; Juan F Lorenzo; Fernando Lozano; Josep Mallolas; José M Miró; Federico Pulido; Esteban Ribera
Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].
Enfermedades infecciosas y microbiología clínica 2004;22(3):160-76.
2004: Eugenia Negredo; José Moltó; David Burger; Pompeyo E. Viciana; Esteban Ribera; Roger Paredes; Manel Juan; Lidia Ruiz; Jordi Puig; Alain Pruvost; Jacques Grassi; Elisabeth Masmitjà; Bonaventura Clotet
Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load.
AIDS (London, England) 2004;18(3):459-63.
2004: Manuel Crespo; J C Paradiñeiro; Esteban Ribera; Isabel Ruiz; Vicenç Falcó; J Lopez-Quiñones; Imma Ocaña; Albert Pahissa
A case of multiorgan failure following interruption of antiretroviral treatment.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(1):63-5.
2003: Carlos Pigrau; Dolors Rodríguez; Ana M Planes; Benito Almirante; N Larrosa; Esteban Ribera; Joan Gavaldà; Albert Pahissa
Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(12):713-9.
2003: Esteban Martínez; Pere Domingo; Esteban Ribera; Ana Milinkovic; Juan A Arroyo; Ignacio Conget; José B Pérez-Cuevas; Roser Casamitjana; Elisa De Lazzari; Luis Bianchi; Enric Montserrat; Merce Roca; Rosa Burgos; Juan A Arnaiz; José M Gatell
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
Antiviral therapy 2003;8(5):403-10.
2003: Lidia Ruiz; Esteban Ribera; Anna Bonjoch; Joan Romeu; Javier Martinez-Picado; Roger Paredes; Marjorie Díaz; Silvia Marfil; Eugenia Negredo; Julia García-Prado; Cristina Tural; Guillem Sirera; Bonaventura Clotet
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
The Journal of infectious diseases 2003;188(7):977-85.
2003: Esteban Martínez; Juan A Arnaiz; Daniel Podzamczer; David Dalmau; Esteban Ribera; Pere Domingo; Hernando Knobel; Melcior Riera; Enric Pedrol; Lluís Force; Josep M Llibre; Ferran Segura; Cristóbal Richart; Cristina Cortés; Manuel Javaloyas; Miquel Aranda; Anna Cruceta; Elisa De Lazzari; José M Gatell
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
The New England journal of medicine 2003;349(11):1036-46.
2003: Ana Barrios; Carmen de Mendoza; Luz Martín-Carbonero; Esteban Ribera; Pere Domingo; María José Galindo; Juan Gálvez; Vicente Estrada; David Dalmau; Victor Asensi; Vincent Soriano
Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.
Journal of clinical microbiology 2003;41(9):4421-3.
2003: Fernando Laguna; Sebastián Videla; Manuel E Jiménez-Mejías; Guillem Sirera; Julián Torre-Cisneros; Esteban Ribera; Dolores Prados; Bonaventura Clotet; Mariano Sust; Rogelio López-Vélez; Jorge Alvar
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
The Journal of antimicrobial chemotherapy 2003;52(3):464-8.
2003: Vicenç Falcó; Manuel Crespo; Esteban Ribera
Lactic acidosis related to nucleoside therapy in HIV-infected patients.
Expert opinion on pharmacotherapy 2003;4(8):1321-9.
2003: Bernardino Roca; Ignacio Suarez; Juan Gonzalez; Myriam Garrido; Belen de la Fuente; Ramon Teira; Paloma Geijo; Jaime Cosin; Salvador Perez-Cortes; María José Galindo; Fernando Lozano; Pere Domingo; Pompeyo E. Viciana; Esteban Ribera; Antonio Vergara; Trinitario Sánchez
Hepatitis C virus and human immunodeficiency virus coinfection in Spain.
The Journal of infection 2003;47(2):117-24.
2003: Alfredo Hidalgo; Vicenç Falcó; S Mauleón; Jordi Andreu; Manuel Crespo; Esteban Ribera; Albert Pahissa; José Cáceres
Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non- Pneumocystis carinii pneumonia in AIDS patients.
European radiology 2003;13(5):1179-84.
2002: Ignacio Suárez-Lozano; José M Fajardo; Myriam Garrido; Bernardino Roca; M Luisa García-Alcalde; Paloma Geijo; Daniel Selma; Fernando Lozano; Ramón Teira; Pompeyo E. Viciana; Salvador Pérez-Cortés; Pere Domingo; Antonia Menchero; María José Galindo; Jaime Cosín; Esteban Ribera; José R Arribas; Juan R Lacalle
Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).
AIDS (London, England) 2002;16(18):2496-9.
2002: Nuria Vallejo Camazón; Dolors Rodríguez Pardo; Antonio Sánchez Hidalgo; María Pilar Tornos Mas; Esteban Ribera; Jordi Soler-Soler
[Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection].
Revista española de cardiología 2002;55(8):878-81.
2002: Esteban Ribera; Koldo Aguirrebengoa; Celia Miralles; Antonio Antela; Antonio Rivero; José Ramón Arribas
[Simplification of antiretroviral treatment].
Enfermedades infecciosas y microbiología clínica 2002;20 Suppl 2():48-57.
2002: Roser Fisa; Cristina Riera; Esteban Ribera; Montserrat Gállego; Montserrat Portús
A nested polymerase chain reaction for diagnosis and follow-up of human visceral leishmaniasis patients using blood samples.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2002;96 Suppl 1():S191-4.
2002: Vicenç Falcó; Dolors Rodríguez; Esteban Ribera; Esteban Martínez; José M Miró; Pere Domingo; Ruth Diazaraque; José R Arribas; Juan J González-García; Francesc Montero; Lluis Sánchez; Albert Pahissa
Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(6):838-46.
2002: Montserrat Gállego; F Pratlong; Cristina Riera; C Muñoz; Esteban Ribera; Roser Fisa; Jean-Antoine Rioux; JP Dedet; Montserrat Portús
Isoenzymatic identification of Leishmania isolates from repeated clinical human leishmaniasis episodes in Catalonia (Spain).
Transactions of the Royal Society of Tropical Medicine and Hygiene 2002;96(1):45-7.
2001: Esteban Ribera; Leonor Pou; Rosa M Lopez; Manuel Crespo; Vicenç Falco; Imma Ocaña; Isabel Ruiz; Albert Pahissa
Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis.
Journal of acquired immune deficiency syndromes (1999) 2001;28(5):450-3.
2001: Esteban Ribera; Leonor Pou; A Fernandez-Sola; F Campos; Rosa M Lopez; Imma Ocaña; Isabel Ruiz; Albert Pahissa
Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2001;45(11):3238-41.
2001: J C Lopez Bernaldo de Quiros; Jose M Miro; Jose Peña; Daniel Podzamczer; Juan C Alberdi; Esteban Martínez; Jaime Cosin; Xavier Claramonte; J Gonzalez; Pere Domingo; J L Casado; Esteban Ribera
A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
The New England journal of medicine 2001;344(3):159-67.
2001: Jaume Carrió; Cristina Riera; Montserrat Gállego; Esteban Ribera; Montserrat Portús
In vitro susceptibility of Leishmania infantum to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patients.
The Journal of antimicrobial chemotherapy 2001;47(1):120-1.
2000: F Martínez-Valle; JA Capdevila; Esteban Ribera; Carlos Pigrau; Albert Pahissa
[A pancreatic pseudotumour of tuberculous etiology].
Medicina clínica 2000;115(12):460-2.
2000: Daniel Podzamczer; José M Miró; Elena Ferrer; José M Gatell; José-María Ramón; Esteban Ribera; Guillem Sirera; Anna Cruceta; Hernando Knobel; Pere Domingo; Rosa Polo; María Leyes; Jaime Cosin; M Carmen Fariñas; Julio Arrizabalaga; Javier Martínez-Lacasa; Francesc Gudiol
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(2):89-95.
1999: Esteban Ribera; A Fernandez-Sola; C Juste; A Rovira; F J Romero; L Armadans-Gil; Isabel Ruiz; Imma Ocaña; Albert Pahissa
Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(6):1461-6.
1998: Esteban Ribera; José M Miró; E Cortés; Anna Cruceta; J Merce; F Marco; Ana M Planes; J C Paré; A Moreno; Imma Ocaña; José M Gatell; Albert Pahissa
Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users.
Archives of internal medicine 1998;158(18):2043-50.
1998: Benito Almirante; M Saballs; Esteban Ribera; Carlos Pigrau; Joan Gavalda; Isabel Gasser; Albert Pahissa
Favorable prognosis of purulent meningitis in patients infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(1):176-80.
1998: J Otero; Esteban Ribera; Joan Gavaldà; A Rovira; Imma Ocaña; Albert Pahissa
Response to acyclovir in two cases of herpes zoster leukoencephalitis and review of the literature.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(4):286-9.
1996: Esteban Ribera; J Gómez-Jimenez; E Cortes; Oscar del Valle; A Planes; T Gonzalez-Alujas; Benito Almirante; Imma Ocaña; Albert Pahissa
Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.
Annals of internal medicine 1996;125(12):969-74.
1996: Isabel Gasser; A Jaén; J González; Esteban Ribera
Diagnosis of visceral leishmaniasis in HIV-infected patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(12):967-8.
1996: Esteban Ribera; Imma Ocaña; J de Otero; E Cortes; Isabel Gasser; Albert Pahissa
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
The American journal of medicine 1996;100(5):496-501.
1995: J de Otero; Benito Almirante; Esteban Ribera; MP Tornos
[Endophthalmitis secondary to bacterial endocarditis].
Medicina clínica 1995;105(18):717-8.
1995: O Len; J de Otero; Esteban Ribera; Imma Ocaña
[Ulcer in the urethral meatus and HIV infection].
Enfermedades infecciosas y microbiología clínica 1995;13(8):497-8.
1995: J Serena; E Cortés; J de Otero; Esteban Ribera
[Guillain-Barré syndrome with anti-HIV seroconversion].
Medicina clínica 1995;105(4):156.
1995: Mª José Martinez-Zapata; J de Otero; A Vallano; Esteban Ribera
[Macroscopic hematuria secondary to the administration of intravenous pentamidine].
Enfermedades infecciosas y microbiología clínica 1995;13(5):324.
1995: J de Otero; M López-Lara; J Paloma; E Gemar; Esteban Ribera; C Pigrau
[Infection by Clostridium septicum as a presenting form of colonic neoplasia].
Enfermedades infecciosas y microbiología clínica 1995;13(5):317-8.
1995: E Cortés; Esteban Ribera; Elena Cucurull; J de Otero; Imma Ocaña; Albert Pahissa
[Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
Medicina clínica 1995;104(15):578-80.
1995: Esteban Ribera; Elena Cucurull; Imma Ocaña; T Vallespí; Isabel Gasser; C Juste
[Visceral leishmaniasis in patients with HIV infection].
Enfermedades infecciosas y microbiología clínica 1995;13(2):73-9.
1995: O Sotorra; P Villalonga; Esteban Ribera; C Mateo; M Castro; C Juste
[Acute retinal necrosis caused by varicella zoster virus].
Enfermedades infecciosas y microbiología clínica 1995;13(2):130-1.
1995: J de Otero; Josep M Suriñach; Esteban Ribera; José Alegre; C Juste; J Río
[Neurologic manifestations of varicella herpes zoster infection].
Enfermedades infecciosas y microbiología clínica 1995;13(1):6-11.
1994: J de Otero; E Cortés; C Pigrau; Esteban Ribera
[Listeriosis in an patient with AIDS].
Medicina clínica 1994;103(3):116.
1993: J de Otero; E Balcells; F Calvo; Esteban Ribera; J C Vicens; J M Martínez Vázquez
[Pyogenic liver abscess and HIV].
Enfermedades infecciosas y microbiología clínica 1993;11(10):576-7.
1993: J Gómez-Jiménez; Esteban Ribera; Isabel Gasser; M A Artaza; Oscar del Valle; Albert Pahissa; J M Martínez-Vázquez
Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.
Antimicrobial agents and chemotherapy 1993;37(8):1587-92.
1992: R Máñez; Isabel Caragol; Esteban Ribera; I Ocaña; Teresa Español; J M Martínez Vázquez
[Immunologic prognostic parameters in infection by the human immunodeficiency virus].
Medicina clínica 1992;99(14):521-4.
1992: J Gómez-Jiménez; Esteban Ribera; J M Martínez-Vázquez; Isabel Gasser; R M Segura
[Bacterial peritonitis in cirrhosis. Prospective study of 80 episodes].
Medicina clínica 1992;99(13):493-7.
1991: Esteban Ribera; J M Martínez Vásquez; I Ocaña; I Ruiz; J G Jimínez; G Encabo; R M Segura; C Pascual
Diagnostic value of ascites gamma interferon levels in tuberculous peritonitis. Comparison with adenosine deaminase activity.
Tubercle 1991;72(3):193-7.
1991: Esteban Ribera; J Gómez Jiménez; J M Martínez Vázquez
[Spontaneous bacterial peritonitis in the cirrhotic patient].
Anales de medicina interna (Madrid, Spain : 1984) 1991;8 Suppl 2():44-8.
1990: Esteban Ribera; X Martínez-Costa; P Tornos; J Gómez-Jiménez; A Planes; Albert Pahissa; J M Martínez-Vázquez
[Infectious endocarditis in drug addicts: a study of 71 cases].
Medicina clínica 1990;95(1):5-9.
1990: Esteban Ribera; Teresa Español; J M Martinez-Vazquez; I Ocaña; G Encabo
Lymphocyte proliferation and gamma-interferon production after "in vitro" stimulation with PPD. Differences between tuberculous and nontuberculous pleurisy in patients with positive tuberculin skin test.
Chest 1990;97(6):1381-5.
1990: Esteban Ribera; J M Martínez-Vázquez; I Ocaña; I Ruiz; R M Segura; G Encabo; C Pascual
[Gamma interferon and adenosine deaminase in pleuritis].
Medicina clínica 1990;94(10):364-7.
1989: X Martínez-Costa; Esteban Ribera; Alfons Segarra; J Gómez-Jiménez; I Gil-Ganalda; J Fort; J M Martínez-Vázquez
[Acute interstitial secondary to tricuspid endocarditis caused by Staphylococcus aureus].
Anales de medicina interna (Madrid, Spain : 1984) 1989;6(11):595-7.
1989: I Gil Canalda; Esteban Ribera; J Gómez Jiménez; X Martínez Costa; J M Martínez Vázquez
[Non-Hodgkin's lymphoma with an atypical presentation and exclusively abdominal localization].
Anales de medicina interna (Madrid, Spain : 1984) 1989;6(10):554-5.
1989: X Martínez-Costa; Esteban Ribera; Albert Pahissa; J M Martínez-Vázquez
[Endocarditis in heroin addicts: incidence in the Vall d'Hebron General Hospital].
Medicina clínica 1989;92(20):794.
1989: R M Segura; C Pascual; I Ocaña; J M Martínez-Vázquez; Esteban Ribera; I Ruiz; M D Pelegrí
Adenosine deaminase in body fluids: a useful diagnostic tool in tuberculosis.
Clinical biochemistry 1989;22(2):141-8.
1988: Esteban Ribera; G Villegas; C Pigrau; A Planes; A Coira; J M Martínez-Vázquez
[Streptococcus agalactiae bacteremia in adults: study of 46 cases admitted to the Hospital Vall d'Hebron (1978-1985)].
Medicina clínica 1988;91(6):211-3.
1988: Esteban Ribera; I Ocaña; Teresa Español; I Ruiz; T Fernández de Sevilla; J M Martínez Vázquez
[Lymphocyte response to mitogens and antigens in pleurisy].
Medicina clínica 1988;91(4):131-4.
1988: I Ocaña; Esteban Ribera; J M Martinez-Vázquez; I Ruiz; E Bejarano; C Pigrau; A Pahissa
Adenosine deaminase activity in rheumatoid pleural effusion.
Annals of the rheumatic diseases 1988;47(5):394-7.
1988: Esteban Ribera; I Ocaña; J M Martinez-Vazquez; M Rossell; Teresa Español; A Ruibal
High level of interferon gamma in tuberculous pleural effusion.
Chest 1988;93(2):308-11.
1987: Esteban Ribera; J M Martinez-Vazquez; I Ocaña; R M Segura; C Pascual
Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults.
The Journal of infectious diseases 1987;155(4):603-7.
1987: C Pigrau; J M Martínez-Vázquez; I Ocaña; R Muñiz; J A Capdevila; Esteban Ribera; A Lorente; M T Vidal; A Moragas
[Clinical study of 31 cases of primary amyloidosis].
Medicina clínica 1987;88(10):399-404.
1986: J M Martinez-Vazquez; Esteban Ribera; I Ocaña; R M Segura; R Serrat; J Sagrista
Adenosine deaminase activity in tuberculous pericarditis.
Thorax 1986;41(11):888-9.
1986: J M Martinez-Vazquez; I Ocaña; Esteban Ribera; R M Segura; C Pascual
Adenosine deaminase activity in the diagnosis of tuberculous peritonitis.
Gut 1986;27(9):1049-53.
1986: I Ocaña; J M Martinez-Vazquez; Esteban Ribera; R M Segura; C Pascual
Adenosine deaminase activity in the diagnosis of lymphocytic pleural effusions of tuberculous, neoplastic and lymphomatous origin.
Tubercle 1986;67(2):141-5.
1985: J M Martínez Vázquez; C Pigrau; I Ocaña; R Muñiz; J A Capdevila; Esteban Ribera
[Clinical evaluation of 66 cases of secondary amyloidosis].
Medicina clínica 1985;85(9):350-5.
1985: C Pigrau; J M Martínez-Vázquez; I Ocaña; J A Capdevila; Esteban Ribera; R Muñiz; M T Vidal
[Usefulness of potassium permanganate staining in the classification of systemic amyloidoses].
Medicina clínica 1985;84(8):302-4.
1984: J M Martinez-Vazquez; J A Capdevila; Esteban Ribera; I Ocaña; R Muñiz
Bronchial carcinoid and parathyroid adenoma.
Annals of internal medicine 1984;100(6):916-7.
1984: Josefa López-Vivancos; Esteban Ribera; Jaime Vilaseca; J M Martínez-Vázquez; J A Capdevila; R Muñiz
[Tuberculous empyema].
Medicina clínica 1984;82(17):778.
1984: G Sánchez; G Villegas; A Sanmartí; J Alom; D Idáñez; Esteban Ribera
[Pulmonary carcinoma associated with a partial deficiency of the antidiuretic hormone].
Medicina clínica 1984;82(2):89-90.